Viral genes as oncolytic agents for cancer therapy

Area of Science:

• Virology
• Molecular Biology
• Cancer Research

Background:

• Viruses possess mechanisms to modulate apoptosis, the programmed cell death process.
• Viral proteins interact with cellular signaling pathways to influence apoptosis.
• Some viruses induce apoptosis in infected cells, while others inhibit it.

Purpose of the Study:

• To review viral genes with selective tumor cell-killing properties.
• To explore the mechanisms of action and signaling pathways involved in viral-mediated cancer cell death.
• To discuss the therapeutic potential of these viral genes as anticancer agents.

Main Methods:

• Literature review of scientific publications on viral genes and apoptosis.
• Analysis of studies detailing viral protein interactions with cellular signaling pathways.
• Examination of research on the selective toxicity of viral genes towards tumor cells.

Main Results:

• Certain viral genes encode proteins that induce apoptosis selectively in cancer cells.
• These viral proteins can trigger cancer cell death without harming normal cells.
• Viral genes demonstrate potential for targeted cancer therapy development.

Conclusions:

• Viral genes with selective cancer cell-killing capabilities represent a promising avenue for novel anticancer therapeutics.
• Understanding their mechanisms of action is crucial for therapeutic development.
• These viral agents offer a strategy for targeted cancer treatment with reduced side effects.